Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
| 4.45 Delayed Data As of 1:17pm ET |  +0.17 / +3.97%Today’s Change | 2.17 Today|||52-Week Range 7.67 | +18.67% Year-to-Date |
Latest CPRX News | Press Releases
| Can Catalyst Pharmaceuticals Stock Rebound in 2020? Jan 22 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 4.28 |
| Today’s open | 4.28 |
| Day’s range | 4.28 - 4.52 |
| Volume | 959,493 |
| Average volume (3 months) | 2,417,701 |
| Market cap | $410.6M |
Data as of 1:17pm ET, 01/29/2020
Growth & Valuation
| Earnings growth (last year) | -57.76% |
| Earnings growth (this year) | +203.54% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 49.4 |
| Price/Sales | 394.11 |
| Price/Book | 8.06 |
Competitors
| ---- | ||
| INOInovio Pharmaceutica... | -0.33 | -7.57% |
| BYSIBeyondspring Inc | -0.34 | -2.16% |
| CRBPCorbus Pharmaceutica... | -0.02 | -0.30% |
Data as of 1:32pm ET, 01/29/2020
Financials
| Next reporting date | March 16, 2020 |
| EPS forecast (this quarter) | $0.10 |
| Annual revenue (last year) | $500.0K |
| Annual profit (last year) | -$34.0M |
| Net profit margin | -6,800.70% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Coral Gables, Florida |
Forecasts
